For decades, Michael J. Fox has faced Parkinson’s disease with honesty, determination, and an unwavering belief in science. Through his foundation, he has helped fund groundbreaking research into better treatments, genetics, biomarkers, and the biological processes behind the disease. One of the most remarkable milestones came in 2023, when researchers identified a biomarker capable of detecting important biological signs of Parkinson’s in living people. The discovery brought fresh optimism, offering scientists new ways to improve clinical trials and move closer to more effective therapies. Despite the physical challenges Parkinson’s continues to bring, Fox has repeatedly shared that scientific progress gives him genuine hope for the future.

That hope became even more meaningful in September 2026 when Fox received the prestigious 2026 Lasker–Bloomberg Public Service Award for transforming Parkinson’s research and reducing stigma around the disease. During the ceremony, he accepted the honor with gratitude before pausing unexpectedly. Then he looked toward the audience, smiled quietly, and said, “The biggest breakthrough may be closer than anyone thinks…”